Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH. (Q55463980)

12 July 2018

title

Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH. (English)

1 reference

12 July 2018

author

John K. Cowell

6

1 reference

12 July 2018

author name string

S Sharma

1

1 reference

12 July 2018

A Free

2

1 reference

12 July 2018

Y Mei

3

1 reference

12 July 2018

S C Peiper

4

1 reference

12 July 2018

Z Wang

5

1 reference

12 July 2018

publication date

16 July 2010

1 reference

12 July 2018

Experimental and Molecular Pathology

published in

1 reference

12 July 2018

volume

89

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

page(s)

169-174

1 reference

12 July 2018

Congenital glioblastoma: a clinicopathologic and genetic analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Genetic alterations in pediatric high-grade astrocytomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Molecular genetic changes in a series of neuroepithelial tumors of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Advances toward an understanding of brainstem gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Genetic sub-types of human malignant astrocytoma correlate with survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Molecular pathogenesis of pediatric astrocytic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Genetic pathways to glioblastoma: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Genetic pathways to primary and secondary glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

7 January 2021

Brain tumors in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Expression of p53 and prognosis in children with malignant gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Pathology and molecular genetics of astrocytic gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Array CGH analysis of pediatric medulloblastomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

High-grade astrocytoma in very young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Pediatric glioblastomas: a histopathological and molecular genetic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.009

10.1016/J.YEXMP.2010.06.009

7 January 2021

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018